{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:51:39Z","timestamp":1784098299831,"version":"3.55.0"},"reference-count":154,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T00:00:00Z","timestamp":1703462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Chair on Pandemic Preparedness within the Access-To-Medicines Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Health emergencies caused by epidemic-prone pathogens (EPPs) have increased exponentially in recent decades. Although vaccines have proven beneficial, they are unavailable for many pathogens. Furthermore, achieving timely and equitable access to vaccines against EPPs is not trivial. It requires decision-makers to capture numerous interrelated factors across temporal and spatial scales, with significant uncertainties, variability, delays, and feedback loops that give rise to dynamic and unexpected behavior. Therefore, despite progress in filling R&amp;D gaps, the path to licensure and the long-term viability of vaccines against EPPs continues to be unclear. This paper presents a quantitative system dynamics modeling framework to evaluate the long-term sustainability of vaccine supply under different vaccination strategies. Data from both literature and 50 expert interviews are used to model the supply and demand of a prototypical Ebolavirus Zaire (EBOV) vaccine. Specifically, the case study evaluates dynamics associated with proactive vaccination ahead of an outbreak of similar magnitude as the 2018\u20132020 epidemic in North Kivu, Democratic Republic of the Congo. The scenarios presented demonstrate how uncertainties (e.g., duration of vaccine-induced protection) and design criteria (e.g., priority geographies and groups, target coverage, frequency of boosters) lead to important tradeoffs across policy aims, public health outcomes, and feasibility (e.g., technical, operational, financial). With sufficient context and data, the framework provides a foundation to apply the model to a broad range of additional geographies and priority pathogens. Furthermore, the ability to identify leverage points for long-term preparedness offers directions for further research.<\/jats:p>","DOI":"10.3390\/vaccines12010024","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T22:59:09Z","timestamp":1703545149000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5238","authenticated-orcid":false,"given":"Donovan","family":"Guttieres","sequence":"first","affiliation":[{"name":"Access-to-Medicines Research Centre, Faculty of Economics & Business, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlot","family":"Diepvens","sequence":"additional","affiliation":[{"name":"Access-to-Medicines Research Centre, Faculty of Economics & Business, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-1729","authenticated-orcid":false,"given":"Catherine","family":"Decouttere","sequence":"additional","affiliation":[{"name":"Access-to-Medicines Research Centre, Faculty of Economics & Business, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-7376","authenticated-orcid":false,"given":"Nico","family":"Vandaele","sequence":"additional","affiliation":[{"name":"Access-to-Medicines Research Centre, Faculty of Economics & Business, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fimmu.2019.00549","article-title":"Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response","volume":"10","author":"Bloom","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_2","unstructured":"G20 High Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response (2023, November 10). Available online: https:\/\/pandemic-financing.org\/report\/foreword\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/23744235.2021.2022195","article-title":"Socio-Economic Impacts of Emerging Infectious Diseases in Africa","volume":"54","author":"Nyaruaba","year":"2022","journal-title":"Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12939-021-01611-2","article-title":"Pandemic Inequalities: Emerging Infectious Diseases and Health Equity","volume":"21","author":"Bambra","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"ref_5","first-page":"27060","article-title":"How Urbanization Affects the Epidemiology of Emerging Infectious Diseases","volume":"5","author":"Neiderud","year":"2015","journal-title":"Afr. J. Disabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmi.2017.03.012","article-title":"Migration and Infectious Diseases","volume":"23","author":"Castelli","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious Disease in an Era of Global Change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41558-022-01426-1","article-title":"Over Half of Known Human Pathogenic Diseases Can Be Aggravated by Climate Change","volume":"12","author":"Mora","year":"2022","journal-title":"Nat. Clim. Chang."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e067510","DOI":"10.1136\/bmj-2021-067510","article-title":"Strengthening the Basics: Public Health Responses to Prevent the next Pandemic","volume":"375","author":"Haldane","year":"2021","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bown, C.P., and Bollyky, T.J. (2021). Working Paper: How COVID-19 Vaccine Supply Chains Emerged in the Midst of a Pandemic, CEPR.","DOI":"10.2139\/ssrn.3902082"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(23)00526-3","article-title":"It Is Time for Ambitious, Transformational Change to the Epidemic Countermeasures Ecosystem","volume":"401","author":"Torreele","year":"2023","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1377\/hlthaff.2020.00103","article-title":"Return on Investment from Immunization against 10 Pathogens in 94 Low-and Middle-Income Countries, 2011\u20132030","volume":"39","author":"Sim","year":"2020","journal-title":"Health Aff."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rodrigues, C.M.C., and Plotkin, S.A. (2020). Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01526"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global Impact of the First Year of COVID-19 Vaccination: A Mathematical Modelling Study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eap.2021.10.006","article-title":"The Economic Reaction to Non-Pharmaceutical Interventions during Covid-19","volume":"72","author":"Teruel","year":"2021","journal-title":"Econ. Anal. Policy"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Stokes, J., Turner, A.J., Anselmi, L., Morciano, M., and Hone, T. (2022). The Relative Effects of Non-Pharmaceutical Interventions on Wave One Covid-19 Mortality: Natural Experiment in 130 Countries. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-13546-6"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine Development for Emerging Infectious Diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."},{"key":"ref_18","unstructured":"WHO (2016). An R&D Blueprint for Action to Prevent Epidemics, WHO."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1080\/21645515.2017.1306615","article-title":"Vaccines for Epidemic Infections and the Role of CEPI","volume":"13","author":"Plotkin","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2018.04.019","article-title":"Sustainable Vaccine Development: A Vaccine Manufacturer\u2019s Perspective","volume":"53","author":"Rappuoli","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e46675","DOI":"10.15252\/embr.201846675","article-title":"Fresh Approaches to Vaccine Development","volume":"19","author":"Gristwood","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gouglas, D., and Marsh, K. (2021). Prioritizing Investments in Rapid Response Vaccine Technologies for Emerging Infections: A Portfolio Decision Analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246235"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/inthealth\/ihu051","article-title":"Vaccination in Humanitarian Crises: Satisficing Should No Longer Suffice","volume":"6","author":"Grais","year":"2014","journal-title":"Int. Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sigfrid, L., Maskell, K., Bannister, P.G., Ismail, S.A., Collinson, S., Regmi, S., Blackmore, C., Harriss, E., Longuere, K.S., and Gobat, N. (2020). Addressing Challenges for Clinical Research Responses to Emerging Epidemics and Pandemics: A Scoping Review. BMC Med., 18.","DOI":"10.1186\/s12916-020-01624-8"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2021014","DOI":"10.4178\/epih.e2021014","article-title":"Inherently High Uncertainty in Predicting the Time Evolution of Epidemics","volume":"43","author":"Park","year":"2021","journal-title":"Epidemiol. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/deci.12609","article-title":"Designing Supply Chain Strategies against Epidemic Outbreaks Such as COVID-19: Review and Future Research Directions","volume":"54","author":"Govindan","year":"2023","journal-title":"Decis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1473-3099(14)70999-5","article-title":"The Development of Global Vaccine Stockpiles","volume":"15","author":"Yen","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100119","DOI":"10.1016\/j.jvacx.2021.100119","article-title":"The Importance of Vaccine Stockpiling to Respond to Epidemics and Remediate Global Supply Shortages Affecting Immunization: Strategic Challenges and Risks Identified by Manufacturers","volume":"9","author":"Jarrett","year":"2021","journal-title":"Vaccine X"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola Virus Disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2051013615611017","article-title":"Clinical Development of Ebola Vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e19036","DOI":"10.1016\/j.heliyon.2023.e19036","article-title":"Brief Review on Ebola Virus Disease and One Health Approach","volume":"9","author":"Hussein","year":"2023","journal-title":"Heliyon"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S698","DOI":"10.1093\/infdis\/jiy213","article-title":"The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa","volume":"218","author":"Huber","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_33","unstructured":"(2023, November 10). Gavi Vaccine Alliance 500,000 Doses of Ebola Vaccine to Be Made Available to Countries for Outbreak Response. Available online: https:\/\/www.gavi.org\/news\/media-room\/500000-doses-ebola-vaccine-be-made-available-countries-outbreak-response."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Parish, L.A., Stavale, E.J., Houchens, C.R., and Wolfe, D.N. (2023). Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA). Vaccines, 11.","DOI":"10.3390\/vaccines11061120"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tim.2018.08.008","article-title":"Can Ebola Virus Vaccines Have Universal Immune Correlates of Protection?","volume":"27","author":"Meyer","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Crozier, I., Britson, K.A., Wolfe, D.N., Klena, J.D., Hensley, L.E., Lee, J.S., Wolfraim, L.A., Taylor, K.L., Higgs, E.S., and Montgomery, J.M. (2022). The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps. Vaccines, 10.","DOI":"10.3390\/vaccines10081213"},{"key":"ref_37","unstructured":"WHO (2021). Meeting of the Strategic Advisory Group of Experts on Immunization, 22\u201324 March 2021: Conclusions and Recommendations, WHO."},{"key":"ref_38","unstructured":"(2023, November 10). UNICEF Market & Supply Update: Ebola Vaccine. Available online: https:\/\/www.unicef.org\/supply\/media\/18971\/file\/VIC-MarketUpdate-Poster-Ebola-2023.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41591-021-01313-w","article-title":"The Need for a New Strategy for Ebola Vaccination","volume":"27","author":"Bausch","year":"2021","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3201\/eid2201.151410","article-title":"Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease","volume":"22","author":"Kucharski","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/514299a","article-title":"Health Workers Bury a Nun in Kikwit in January 1995, during an Ebola Outbreak in Zaire That Killed 254 People","volume":"514","author":"Heymann","year":"2014","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Senga, M., Koi, A., Moses, L., Wauquier, N., Barboza, P., Fernandez-Garcia, M.D., Engedashet, E., Kuti-George, F., Mitiku, A.D., and Vandi, M. (2017). Contact Tracing Performance during the Ebola Virus Disease Outbreak in Kenema District, Sierra Leone. Philos. Trans. R. Soc. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0300"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","article-title":"Prevention of Ebola Virus Disease through Vaccination: Where We Are in 2018","volume":"392","author":"Lane","year":"2018","journal-title":"Lancet"},{"key":"ref_44","unstructured":"Africa Centres for Disease Control and Prevention (Africa CDC) (2023). Risk Ranking and Prioritization of Epidemic-Prone Diseases, Africa CDC."},{"key":"ref_45","unstructured":"(2023, November 10). US CDC Ebola Disease Outbreaks by Species and Size, Since 1976, Available online: https:\/\/www.cdc.gov\/vhf\/ebola\/history\/distribution-map.html."},{"key":"ref_46","unstructured":"Pruyt, E. (2013). Small System Dynamics Models for Big Issues: Triple Jump towards Real-World Dynamic Complexity, TU Delft Library."},{"key":"ref_47","unstructured":"(2023, December 07). Isee Systems How Model Equations Are Solved. Available online: https:\/\/www.iseesystems.com\/resources\/help\/v10\/Content\/Reference\/Integration%20methods\/How_model_equations_are_solved.htm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1057\/palgrave.jors.2600961","article-title":"Introduction to System Dynamics Modeling with DYNAMO","volume":"48","author":"Richardson","year":"1997","journal-title":"J. Oper. Res. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100325","DOI":"10.1016\/j.eclinm.2020.100325","article-title":"A Systems Approach to Preventing and Responding to COVID-19","volume":"21","author":"Bradley","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1007\/s11356-021-15902-2","article-title":"System Dynamics Analysis of COVID-19 Prevention and Control Strategies","volume":"29","author":"Jia","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/sdr.1673","article-title":"Behavioral Dynamics of COVID-19: Estimating Underreporting, Multiple Waves, and Adherence Fatigue across 92 Nations","volume":"37","author":"Rahmandad","year":"2021","journal-title":"Syst. Dyn. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sansone, M., Holmstrom, P., Hallberg, S., Nord\u00e9n, R., Andersson, L.M., and Westin, J. (2022). System Dynamic Modelling of Healthcare Associated Influenza -a Tool for Infection Control. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-07959-7"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11518-013-5220-y","article-title":"Integrating Complex System Dynamics of Pandemic Influenza with a Multi-Criteria Decision Making Model for Evaluating Public Health Strategies","volume":"22","author":"Maraz","year":"2013","journal-title":"J. Syst. Sci. Syst. Eng."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/jix108","article-title":"Lessons from the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission","volume":"216","author":"Thompson","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/sres.2329","article-title":"Ebola in West Africa: Model-Based Exploration of Social Psychological Effects and Interventions","volume":"32","author":"Pruyt","year":"2015","journal-title":"Syst. Res. Behav. Sci."},{"key":"ref_56","unstructured":"Sharareh, N., Sabounchi, N.S., and Sayama, H. (2016). The Ebola Crisis and the Corresponding Public Behavior: A System Dynamics Approach The Ebola Crisis and the Corresponding Public Behavior. PLoS Curr., 8."},{"key":"ref_57","first-page":"53","article-title":"Simulating Endogenous Dynamics of Intervention-Capacity Deployment: Ebola Outbreak in Liberia","volume":"4","author":"Auping","year":"2017","journal-title":"Int. J. Syst. Sci. Oper. Logist."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Duintjer Tebbens, R.J., Pallansch, M.A., Wassilak, S.G.F., Cochi, S.L., and Thompson, K.M. (2016). Characterization of Outbreak Response Strategies and Potential Vaccine Stockpile Needs for the Polio Endgame. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1465-7"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14760584.2017.1322514","article-title":"Poliovirus Vaccination during the Endgame: Insights from Integrated Modeling","volume":"16","author":"Thompson","year":"2017","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"101602","DOI":"10.1016\/j.seps.2023.101602","article-title":"Supply Chain Planning of Vaccine and Pharmaceutical Clusters under Uncertainty: The Case of COVID-19","volume":"87","author":"Kochakkashani","year":"2023","journal-title":"Socioecon. Plann Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Shiri, M., and Ahmadizar, F. (2022). An Equitable and Accessible Vaccine Supply Chain Network in the Epidemic Outbreak of COVID-19 under Uncertainty. J. Ambient. Intell. Humaniz. Comput.","DOI":"10.1007\/s12652-022-03865-2"},{"key":"ref_62","first-page":"100285","article-title":"Interventions in Demand and Supply Sides for Vaccine Supply Chain: An Analysis on Monkeypox Vaccine","volume":"11","author":"Sayarshad","year":"2023","journal-title":"Oper. Res. Perspect."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.socscimed.2018.12.021","article-title":"Dynamics of Intervention Adoption, Implementation, and Maintenance inside Organizations: The Case of an Obesity Prevention Initiative","volume":"224","author":"Jalali","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/sdr.462","article-title":"Reflections on the Foundations of System Dynamics","volume":"27","author":"Richardson","year":"2011","journal-title":"Syst. Dyn. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/sdr.261","article-title":"All Models Are Wrong: Reflections on Becoming a Systems Scientist","volume":"18","author":"Sterman","year":"2002","journal-title":"Syst. Dyn. Rev."},{"key":"ref_66","unstructured":"Decouttere, C., Vandaele, N., Lemmens, S., and Bernuzzi, M. (2016). International Series in Operations Research and Management Science, Springer."},{"key":"ref_67","unstructured":"Sterman, J. (2000). Business Dynamics: Systems Thinking and Modeling for a Complex World, Irwin\/McGraw-Hill. [6th ed.]."},{"key":"ref_68","unstructured":"Barlas, Y. (1994, January 11\u201315). Model Validation in System Dynamics. Proceedings of the 1994 International System Dynamics Conference, Stirling, UK."},{"key":"ref_69","unstructured":"Kuzma, J., Grieger, K., Cummings, C., and Brown, Z. (2023, November 10). Pandemics Call for Systems Approaches to Research and Funding. Available online: https:\/\/issues.org\/pandemics-call-for-systems-approaches\/."},{"key":"ref_70","unstructured":"Meadows, D. (2023, November 10). Leverage Points: Places to Intervene in a System. Available online: https:\/\/donellameadows.org\/archives\/leverage-points-places-to-intervene-in-a-system\/."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2471\/BLT.17.205005","article-title":"Building a Global Atlas of Zoonotic Viruses","volume":"96","author":"Carroll","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Doelger, J., Chakraborty, A.K., and Kardar, M. (2022). A Simple Model for How the Risk of Pandemics from Different Virus Families Depends on Viral and Human Traits. Math. Biosci., 343.","DOI":"10.1016\/j.mbs.2021.108732"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JVI.03118-12","article-title":"Molecular Evolution of Viruses of the Family Filoviridae Based on 97 Whole-Genome Sequences","volume":"87","author":"Carroll","year":"2013","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The Virion Glycoproteins of Ebola Viruses Are Encoded in Two Reading Frames and Are Expressed through Transcriptional Editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/cr.2015.54","article-title":"Network of Co-Mutations in Ebola Virus Genome Predicts the Disease Lethality","volume":"25","author":"Deng","year":"2015","journal-title":"Cell Res."},{"key":"ref_76","first-page":"e02185-18","article-title":"Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity","volume":"93","author":"Wong","year":"2018","journal-title":"J. Virlogy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e02227-14","DOI":"10.1128\/mBio.02227-14","article-title":"Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics","volume":"6","author":"Kugelman","year":"2015","journal-title":"mBio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature19790","article-title":"The Evolution of Ebola Virus: Insights from the 2013-2016 Epidemic","volume":"538","author":"Holmes","year":"2016","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Judson, S.D., Fischer, R., Judson, A., and Munster, V.J. (2016). Ecological Contexts of Index Cases and Spillover Events of Different Ebolaviruses. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005780"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e04395","DOI":"10.7554\/eLife.04395","article-title":"Mapping the Zoonotic Niche of Ebola Virus Disease in Africa","volume":"3","author":"Pigott","year":"2014","journal-title":"elife"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3201\/eid2303.160101","article-title":"Spatiotemporal Fluctuations and Triggers of Ebola Virus Spillover","volume":"23","author":"Schmidt","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/s41467-019-12499-6","article-title":"Impacts of Environmental and Socio-Economic Factors on Emergence and Epidemic Potential of Ebola in Africa","volume":"10","author":"Redding","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lee-Cruz, L., Lenormand, M., Cappelle, J., Caron, A., De Nys, H., Peeters, M., Bourgarel, M., Roger, F., and Tran, A. (2021). Mapping of Ebola Virus Spillover: Suitability and Seasonal Variability at the Landscape Scale. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009683"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Telford Mph, C.T., Amman Phd, B.R., Towner, J.S., Bowden Phd, S., Montgomery, J.M., Lessler, J., and Shoemaker Phd, T. (2023). A Predictive Model of Ebolavirus Spillover Incorporating Change in Forests and Human Populations across Spatial and Temporal Scales. medRxiv.","DOI":"10.1101\/2023.08.29.23294795"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Craig, C. (2018). How Does Government Listen to Scientists?, Springer International Publishing.","DOI":"10.1007\/978-3-319-96086-9"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"100547","DOI":"10.1016\/j.epidem.2022.100547","article-title":"Challenges in Estimation, Uncertainty Quantification and Elicitation for Pandemic Modelling","volume":"38","author":"Swallow","year":"2022","journal-title":"Epidemics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100520","DOI":"10.1016\/j.epidem.2021.100520","article-title":"Communicating Uncertainty in Epidemic Models","volume":"37","author":"McCabe","year":"2021","journal-title":"Epidemics"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.1817329116","article-title":"Ebola Vaccination in the Democratic Republic of the Congo","volume":"116","author":"Wells","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Chowell, G., and Kiskowski, M. (2016). Mathematical and Statistical Modeling for Emerging and Re-Emerging Infectious Diseases: Modeling Ring-Vaccination Strategies to Control Ebola Virus Disease Epidemics, Springer.","DOI":"10.1007\/978-3-319-40413-4_6"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3934\/jimo.2017054","article-title":"Ebola Model and Optimal Control with Vaccination Constraints","volume":"14","author":"Area","year":"2017","journal-title":"J. Ind. Manag. Optim."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.epidem.2019.03.001","article-title":"Control of Ebola Virus Disease Outbreaks: Comparison of Health Care Worker-Targeted and Community Vaccination Strategies","volume":"27","author":"Robert","year":"2019","journal-title":"Epidemics"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chen, P., Fan, W., and Guo, X. (2021). A Hybrid Simulation Model to Study the Impact of Combined Interventions on Ebola Epidemic. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0254044"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1017\/S0950268806007217","article-title":"Understanding the Dynamics of Ebola Epidemics","volume":"135","author":"Legrand","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Potluri, R., Kumar, A., Oriol-mathieu, V., Van Effelterre, T., Metz, L., and Bhandari, H. (2022). Model-Based Evaluation of the Impact of Prophylactic Vaccination Applied to Ebola Epidemics in Sierra Leone and Democratic Republic of Congo. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07723-6"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0021-9991(76)90041-3","article-title":"A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions","volume":"22","author":"Gillespie","year":"1976","journal-title":"J. Comput. Phys."},{"key":"ref_96","unstructured":"Miller, M., Barrett, S., and Henderson, D.A. (2006). Disease Control Priorities in Developing Countries, The World Bank."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e000065","DOI":"10.1136\/bmjgh-2016-000065","article-title":"\u2018Women and Babies Are Dying but Not of Ebola\u2019: The Effect of the Ebola Virus Epidemic on the Availability, Uptake and Outcomes of Maternal and Newborn Health Services in Sierra Leone","volume":"1","author":"Jones","year":"2016","journal-title":"BMJ Glob. Health"},{"key":"ref_98","first-page":"1085","article-title":"The Effect of Ebola Virus Disease on Maternal and Child Health Services and Child Mortality in Sierra Leone, 2014\u20132015: Implications for COVID-19","volume":"104","author":"Ngo","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_99","unstructured":"WHO (2015). Health Worker Ebola Infections in Guinea, Liberia and Sierra Leone: A Preliminary Report, WHO."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/S2214-109X(15)00065-0","article-title":"Health-Care Worker Mortality and the Legacy of the Ebola Epidemic","volume":"3","author":"Evans","year":"2015","journal-title":"Lancet Glob. Health"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/jiaa747","article-title":"Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo","volume":"226","author":"Doshi","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular Evidence of Sexual Transmission of Ebola Virus","volume":"373","author":"Mate","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1016\/S2214-109X(20)30454-X","article-title":"Vaccination of Contacts of Ebola Virus Disease Survivors to Prevent Further Transmission","volume":"8","author":"Doshi","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","article-title":"Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks","volume":"597","author":"Keita","year":"2021","journal-title":"Nature"},{"key":"ref_105","first-page":"240","article-title":"Ebola Virus Infection Associated with Transmission from Survivors","volume":"25","author":"Marston","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/epidemiologia3010007","article-title":"Estimating Risk of Introduction of Ebola Virus Disease from the Democratic Republic of Congo to Tanzania: A Qualitative Assessment","volume":"3","author":"Rugarabamu","year":"2022","journal-title":"Epidemiologia"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Dada, S., McKay, G., Mateus, A., and Lees, S. (2019). Lessons Learned from Engaging Communities for Ebola Vaccine Trials in Sierra Leone: Reciprocity, Relatability, Relationships and Respect (the Four R\u2019s). BMC Public. Health, 19.","DOI":"10.1186\/s12889-019-7978-4"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(19)30063-5","article-title":"Institutional Trust and Misinformation in the Response to the 2018\u201319 Ebola Outbreak in North Kivu, DR Congo: A Population-Based Survey","volume":"19","author":"Vinck","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1016\/j.vaccine.2022.04.094","article-title":"Setting-up an Ebola Vaccine Trial in a Remote Area of the Democratic Republic of the Congo: Challenges, Mitigations, and Lessons Learned","volume":"40","author":"Lemey","year":"2022","journal-title":"Vaccine"},{"key":"ref_110","unstructured":"WHO (2016). Ebola Virus Disease (EVD) Vaccine Target Product Profile, WHO."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"B73","DOI":"10.1016\/j.vaccine.2012.11.036","article-title":"The Imperative for Stronger Vaccine Supply and Logistics Systems","volume":"31","author":"Zaffran","year":"2013","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1080700","DOI":"10.3389\/fpubh.2023.1080700","article-title":"Ebola Vaccine Uptake and Attitudes among Healthcare Workers in North Kivu, Democratic Republic of the Congo, 2021","volume":"11","author":"Doshi","year":"2023","journal-title":"Front. Public Health"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and Effectiveness of an RVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results from the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Camacho","year":"2017","journal-title":"Lancet"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"100506","DOI":"10.1016\/j.epidem.2021.100506","article-title":"Challenges of Evaluating and Modelling Vaccination in Emerging Infectious Diseases","volume":"37","author":"Madewell","year":"2021","journal-title":"Epidemics"},{"key":"ref_115","unstructured":"(2023, November 10). US FDA Code of Federal Regulations Title 21, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=314&showFR=1&subpartNode=21:5.0.1.1.4.9."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-020-00261-9","article-title":"Nonhuman Primate to Human Immunobridging to Infer the Protective Effect of an Ebola Virus Vaccine Candidate","volume":"5","author":"Roozendaal","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-022-00564-z","article-title":"Non-Human Primate to Human Immunobridging Demonstrates a Protective Effect of Ad26.ZEBOV, MVA-BN-Filo Vaccine against Ebola","volume":"7","author":"Bockstal","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of Protective Immunity for Ebola Vaccines: Implications for Regulatory Approval by the Animal Rule","volume":"7","author":"Sullivan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of Vaccine-Induced Immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_120","unstructured":"WHO (2022). Emergency Use of Unproven Clinical Interventions Outside Clinical Trials: Ethical Considerations, WHO."},{"key":"ref_121","unstructured":"WHO (2019). Emergency Use Listing Procedure, WHO."},{"key":"ref_122","unstructured":"WHO (2017). Meeting of the Strategic Group of Experts on Immunization, April 2017\u2014Conclusions and Recommendations, WHO."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"100075","DOI":"10.1016\/j.jvacx.2020.100075","article-title":"Alignment in Post-Approval Changes (PAC) Guidelines in Emerging Countries May Increase Timely Access to Vaccines: An Illustrative Assessment by Manufacturers","volume":"6","author":"Dellepiane","year":"2020","journal-title":"Vaccine X"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3201\/eid1309.070372","article-title":"Precautionary Behavior in Response to Perceived Threat of Pandemic Influenza","volume":"13","author":"Sadique","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Wilder-Smith, A., Longini, I., Zuber, P.L., B\u00e4rnighausen, T., Edmunds, W.J., Dean, N., Spicher, V.M., Benissa, M.R., and Gessner, B.D. (2017). The Public Health Value of Vaccines beyond Efficacy: Methods, Measures and Outcomes. BMC Med., 15.","DOI":"10.1186\/s12916-017-0911-8"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1016\/j.vaccine.2016.08.090","article-title":"Beyond Cost-Effectiveness: Using Systems Analysis for Infectious Disease Preparedness","volume":"35","author":"Phelps","year":"2017","journal-title":"Vaccine"},{"key":"ref_127","unstructured":"(2023, December 07). isee systems Statistical Builtins. Available online: https:\/\/www.iseesystems.com\/resources\/help\/v1-8\/Content\/08-Reference\/07-Builtins\/Statistical_builtins.htm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/kpm.1656","article-title":"COVID-19 Induced Emergent Knowledge Strategies","volume":"28","author":"Bratianu","year":"2021","journal-title":"Knowl. Process Manag."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1093\/infdis\/jiad362","article-title":"Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation","volume":"228","author":"Dupuy","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/S0140-6736(22)00793-0","article-title":"Closing the Global Vaccine Equity Gap: Equitably Distributed Manufacturing","volume":"399","author":"Dzau","year":"2022","journal-title":"Lancet"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e1658","DOI":"10.1016\/S2214-109X(23)00328-5","article-title":"From Private Incentives to Public Health Need: Rethinking Research and Development for Pandemic Preparedness","volume":"11","author":"Torreele","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/infdis\/jix584","article-title":"Ebola Virus Neutralizing Antibodies Detectable in Survivors of TheYambuku, Zaire Outbreak 40 Years after Infection","volume":"217","author":"Rimoin","year":"2018","journal-title":"Journal of Infectious Diseases"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Meakin, S.R., Tildesley, M.J., Davis, E., and Keeling, M.J. (2019). A Metapopulation Model for the 2018 Ebola Virus Disease Outbreak in Equateur Province in the Democratic Republic of the Congo. bioRxiv.","DOI":"10.1101\/465062"},{"key":"ref_134","unstructured":"(2023, November 10). UN Population Fund World Population Dashboard Congo, the Democratic Republic of the. Available online: https:\/\/www.unfpa.org\/data\/world-population\/CD."},{"key":"ref_135","unstructured":"(2023, November 10). The World Bank Physicians (per 1,000 People). Available online: https:\/\/data.worldbank.org\/indicator\/SH.MED.PHYS.ZS."},{"key":"ref_136","unstructured":"(2023, November 10). The World Bank Nurses and Midwives (per 1,000 People). Available online: https:\/\/data.worldbank.org\/indicator\/SH.MED.NUMW.P3."},{"key":"ref_137","unstructured":"Ripani, T. (2023, November 10). In DRC, a Young UN Volunteer Tries to Make a Difference in People\u2019s Lives. Available online: https:\/\/www.unv.org\/Success-stories\/drc-young-un-volunteer-tries-make-difference-peoples-lives."},{"key":"ref_138","unstructured":"Henao Restrepo, A.M. (2023, November 10). Ebola Vaccines Powering the World\u2019s Pandemic Response\u2013Now and in the Future. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/9.-ana-maria_session-2_ebola-vax-update_who-consult-afirm_30march2022.pdf?sfvrsn=920308d0_7."},{"key":"ref_139","unstructured":"(2023, November 10). WHO Ebola Virus Disease-African Region (AFRO), Democratic Republic of the Congo. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2020-DON284."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(04)17482-5","article-title":"Human Resources for Health: Overcoming the Crisis","volume":"364","author":"Chen","year":"2004","journal-title":"Lancet"},{"key":"ref_141","unstructured":"(2023, November 10). Financing Alliance for Health Investment in Community Health Workers: A Necessity, Not an Option. Available online: https:\/\/financingalliance.org\/investment-in-community-health-workers-a-necessity-not-an-option\/#:~:text=Over%20the%20years%2C%20the%20rate,at%2040%25%5B2%5D."},{"key":"ref_142","unstructured":"Bedford, J. (2023, November 10). Key Considerations: The Context of North Kivu Province, DRC. Available online: www.socialscienceinaction.org."},{"key":"ref_143","unstructured":"(2023, November 10). European Medicines Agency Summary of Product Characteristics: Zabdeno. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zabdeno#product-information-section."},{"key":"ref_144","unstructured":"(2023, November 10). European Medicines Agency Summary of Product Characteristics: Ervebo. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ervebo#:~:text=Ervebo%20contains%20a%20virus%20known,or%20no%20effect%20on%20humans."},{"key":"ref_145","unstructured":"(2023, November 10). CDC Expanded Access Investigational New Drug (IND) Protocol: Ervebo \u00ae (Ebola Zaire Vaccine, Live) Booster Dose for Domestic Pre-Exposure Prophylaxis (PrEP) Vaccination of Adults (\u226518 Years of Age) at Potential Occupational Risk for Exposure to Zaire Ebolavirus; 2022, Available online: https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-vaccine-protocol_508.pdf."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1016\/j.vaccine.2022.09.037","article-title":"Immunogenicity of RVSV\u0394G-ZEBOV-GP Ebola Vaccine (ERVEBO\u00ae) in African Clinical Trial Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2\/3 Trials","volume":"40","author":"Simon","year":"2022","journal-title":"Vaccine"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.2147\/RMHP.S327616","article-title":"The 2018\u20132020 Ebola Outbreak in the Democratic Republic of Congo: A Better Response Had Been Achieved Through Inter-State Coordination in Africa","volume":"14","author":"Wadoum","year":"2021","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"McLean, C., Dijkman, K., Gaddah, A., Keshinro, B., Katwere, M., Douoguih, M., Robinson, C., Solforosi, L., Czapska-Casey, D., and Dekking, L. (2023). Persistence of Immunological Memory as a Potential Correlate of Long-Term, Vaccine-Induced Protection against Ebola Virus Disease in Humans. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1215302"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm7145a5","article-title":"Notes from the Field: Outbreak of Ebola Virus Disease Caused by Sudan Ebolavirus\u2014Uganda, August\u2013October 2022","volume":"71","author":"Kiggundu","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_150","unstructured":"(2023, November 10). WHO Ebola Trial Candidate Vaccines in Uganda in Record 79 after Outbreak Declared. Available online: https:\/\/www.who.int\/news\/item\/09-12-2022-ebola-trial-candidate-vaccines-arrive-in-uganda-in-record-79-days-after-outbreak-declared#:~:text=%C2%A9-,Ebola%20trial%20candidate%20vaccines%20arrive%20in%20Uganda,79%20days%20after%20outbreak%20declared&text=The%20first%20doses%20of%20one,Against%20Ebola%20or%20Tokomeza%20Ebola."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-020-0204-7","article-title":"Applying Lessons from the Ebola Vaccine Experience for SARS-CoV-2 and Other Epidemic Pathogens","volume":"5","author":"Wolf","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_152","unstructured":"(2023, November 10). WHO Expert Committee on Biological Standardization Annex 4: Guidelines on Procedures and Data Requirements for Changes to Approved Vaccines; 2015. Available online: https:\/\/www.who.int\/publications\/m\/item\/procedures-and-data-requirements-changes-to-approved-vaccines-annex-4-trs-no-993."},{"key":"ref_153","unstructured":"(2023, November 10). WHO Ebola Vaccine Dashboard. Available online: https:\/\/www.who.int\/groups\/icg\/ebola-virus-disease."},{"key":"ref_154","unstructured":"(2023, November 10). UNICEF Ebola Vaccine Price Data. Available online: https:\/\/www.unicef.org\/supply\/documents\/ebola-vaccine-pricing-data."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/1\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:51Z","timestamp":1760132511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/1\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["vaccines12010024"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12010024","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}